Charnwood Molecular, a drug discovery CRO that specializes in enhancing the experience and success of complex drug discovery for clients globally, rebranded to Charnwood Discovery. The rebranding reflects Charnwood Discovery’s evolution over the last 25 years into a partner for companies requiring standalone customized solutions though to fully integrated drug discovery. The company has experience and expertise in bioscience, ADME/DMPK and computer-aided drug design, in addition to discovery ...